Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Sep 8, 2025 | Claims, High-cost claims, Stop-Loss
Stop-loss coverage is no longer just a safeguard – it’s essential for protecting your plan against escalating financial risk. Between 2013 and 2024, the frequency of claims exceeding $2 million grew by more than 1,250%, underscoring why having strong protection in...
Aug 12, 2025 | Cancer, Chronic conditions, Heart disease, MedBen WellLiving, Preventive Care, Stop-Loss, Wellness, Wellness exam, Wellness screenings
In its 2025 High-Cost Claims and Injectable Drug Trend Analysis, Sun Life highlights a familiar but costly trend: malignant neoplasm (cancer) and cardiovascular disease continue to rank among the top drivers of stop-loss claim reimbursements. These chronic conditions...
Apr 22, 2025 | Compliance, Genomics, MedBen University, Mental health parity, Roundtables, Stop-Loss, Wellness
Nearly 50 clients and brokers attended the MedBen University (MBU) 2025 Employer Roundtable on April 9. Industry professionals from MedBen, Sun Life, and Profero Team provided attendees with outside-the-box ways to blend benefits management and employee well-being,...
Feb 11, 2025 | Benefits Advisory Conference, Benefits management, Caroline Fraker, Compliance, Forensic claims review, MedBen University, No Surprises Act (NSA), Pharmacy, Stop-Loss, Wellness
Over 70 guests from seven states attended the MedBen 2025 Benefits Advisory Conference on January 30. Featuring some of the most respected names in the industry, this invitation-only event provided brokers with an extensive look at the state of benefits...
Jul 9, 2024 | Cancer, Claims, Client Report, Heart, Heart disease, High-cost claims, MedBen WellLiving, Preventive Care, Stop-Loss, Wellness, Wellness exam, Wellness screenings
Cardiovascular disease (CVD) has risen to second place on the list of top stop-loss reimbursements, according to Sun Life’s annual report of high-cost claims – the first time the condition has ranked so high. As in past years, the report underlines the...
